These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1465086)

  • 1. Fibronectin metabolism in isolated glomeruli from obese Zucker rats.
    Teschner M; Paczek L; Schaefer RM; Heidland A
    Miner Electrolyte Metab; 1992; 18(2-5):89-91. PubMed ID: 1465086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraglomerular fibronectin accumulation and degradation in obese Zucker rats.
    Paczek L; Teschner M; Schaefer RM; Heidland A
    Diabetologia; 1991 Nov; 34(11):786-9. PubMed ID: 1769435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obese Zucker rat: potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis.
    Teschner M; Paczek L; Schaefer RM; Heidland A
    Res Exp Med (Berl); 1991; 191(2):129-35. PubMed ID: 1857891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies.
    O'Donnell MP; Kasiske BL; Cleary MP; Keane WF
    J Lab Clin Med; 1985 Nov; 106(5):605-10. PubMed ID: 4056571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of genetic obesity on renal structure and function in the Zucker rat.
    Kasiske BL; Cleary MP; O'Donnell MP; Keane WF
    J Lab Clin Med; 1985 Nov; 106(5):598-604. PubMed ID: 4056570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glomerular proteinases in the evolution of glomerulosclerosis.
    Schaefer RM; Paczek L; Huang S; Teschner M; Schaefer L; Heidland A
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):641-6. PubMed ID: 1493156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rofecoxib decreases renal injury in obese Zucker rats.
    Dey A; Maric C; Kaesemeyer WH; Zaharis CZ; Stewart J; Pollock JS; Imig JD
    Clin Sci (Lond); 2004 Dec; 107(6):561-70. PubMed ID: 15307815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination.
    Renaud IM; Chainey A; Belair MF; Mandet C; Michel O; Myara I; Chevalier J; Plante GE
    Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model.
    Floege J; Alpers CE; Burns MW; Pritzl P; Gordon K; Couser WG; Johnson RJ
    Lab Invest; 1992 Apr; 66(4):485-97. PubMed ID: 1583888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic training and diabetic nephropathy in the obese Zucker rat.
    Ward KM; Mahan JD; Sherman WM
    Ann Clin Lab Sci; 1994; 24(3):266-77. PubMed ID: 8048799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.
    Blouin RA; Dickson P; McNamara PJ; Cibull M; McClain C
    J Pharmacol Exp Ther; 1987 Nov; 243(2):565-70. PubMed ID: 3681696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Approach of cellular mechanisms of glomerulosclerosis in a model of accelerated aging the obese Zucker rat].
    Chevalier J; Masurier C; Lavaud S; Michel O; Bariety J
    C R Seances Soc Biol Fil; 1995; 189(6):987-1007. PubMed ID: 8763029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral hypothalamic serotonergic responsiveness to food intake in rat obesity as measured by microdialysis.
    Mori RC; Guimarães RB; Nascimento CM; Ribeiro EB
    Can J Physiol Pharmacol; 1999 Apr; 77(4):286-92. PubMed ID: 10535677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphagia as a mediator of renal disease initiation in obese Zucker rats.
    Stevenson FT; Wheeldon CM; Gades MD; van Goor H; Stern JS
    Obes Res; 2001 Aug; 9(8):492-9. PubMed ID: 11500530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in glomerular proteoglycan metabolism in experimental non-insulin dependent diabetes mellitus.
    Fioretto P; Keane WF; Kasiske BL; O'Donnell MP; Klein DJ
    J Am Soc Nephrol; 1993 Apr; 3(10):1694-704. PubMed ID: 8318686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
    Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
    Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of gluconeogenesis by epinephrine in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
    Sánchez-Gutiérrez JC; Sánchez-Arias JA; Samper B; Felíu JE
    Arch Biochem Biophys; 2000 Jan; 373(1):249-54. PubMed ID: 10620345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
    Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M
    Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness.
    Bergijk EC; Baelde HJ; de Heer E; Killen PD; Bruijn JA
    Exp Nephrol; 1995; 3(6):338-47. PubMed ID: 8528678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.